San Antonio’s innovative nanotherapy company working to improve the safety and efficacy of chemotherapy drugs.

Biomedical Development Corporation is commercializing a portfolio of pharmaceuticals that decrease bacterial bioburden in the mouth, reduce chronic inflammation, and subsequently improve systemic health. Biomedical Development Corporation has two drugs in Phase 2 clinical trials.

BME’s business initiatives as a medical device manufacturer and research service provider have allowed it to increase the medical community’s knowledge in osteoporosis, bone healing, and bone replacement materials. BME's strategy is focused on minimally invasive orthopaedic instrumentation and implants that elicit a biologic response.

BioNumerik Pharmaceuticals, Inc. is focused on the discovery, development and commercialization of novel drugs for the treatment of cancer and cancer supportive care.  The company currently has two drug candidates, Karenitecin (BNP1350) and Tavocept, in late-stage clinical development.

Bone Bank Allografts is located in San Antonio, Texas and is the distributor of the SteriGraft™ line of high quality bone and soft tissue allografts to medical professionals. The company has been in existence for over 13 years and has helped doctors and their patients with over one hundred thousand successful transplantations.

CimMed Inc. provides sales, service and training to medical professionals in hospitals and burn centers. Our products are used for the creation of compression masks used in burn scar management, and in the creation of custom-fit compression garments.

CMI, a woman-owned, small disadvantaged business, is a biotechnology and software engineering company with core competencies in biological research, bioinformatics, modeling, and simulation. CMI's commercial product is an Electronic Health Record called SevocityTM.

A contract development and manufacturing organization (CDMO) offering full service sourcing solutions for the world’s leading pharmaceutical, biotechnology and healthcare companies.

At ENTrigue Surgical, Inc., we are harnessing breakthroughs in biotechnology and instrument design to develop novel, yet sensible solutions for the ENT operating room and office. Our initial focus is on enhancing surgical access for increased functionality and precision. In addition, we are also developing a unique class of proven bioabsorbable and biologic implants designed to simplify surgical procedures and improve healing.

Evestra seeks to improve the health and wellness of women around the world through innovative technologies and commercially viable products focused primarily on fertility control, gynecological disorders and oncology.

A development stage oncology company focused on therapeutics which deliver a potent, unique and patented drug directly to tumors.

Genzyme Corporation is developing and commercializing novel treatments for cancer through internal research and active collaborations.  Marketed products are Campath® and Clolar®.

KCI is a global medical technology company that designs and manufactures a wide range of proprietary products that can improve clinical outcomes and can help reduce the overall cost of patient care.

At Medtronic, Innovating for life means we’re committed to finding more ways to help more people around the world. Constantly pushing the limits of medical technology. Driven by our deep understanding of the human body and our collaboration with physicians, we're transforming technology to treat patients across the entire care continuum. Our innovations help physicians diagnose diseases earlier, treat patients with the least amount of disruption possible, and help alleviate symptoms throughout the patient's life.

For more than sixty years, privately held Mission Pharmacal has been dedicated to identifying unmet health needs and developing innovative products to meet them.

An emerging leader innovating aptamer-based, hand-held diagnostic assay development that eliminates culture enrichment for real-time, rapid testing for food/water safety, homeland security.

QualTex Laboratories performs testing services for clients that collect, prepare, and distribute FDA regulated blood components/biological products for human therapies. Tests performed are used to qualify blood/plasma donors and support global public safety.

Rochal Industries is a privately owned bioscience company focusing on the development of new polymeric materials for wound and burn care treatment.  Rochal licenses its intellectual property to companies capable of commercializing the resulting products.

Seno Medical Instruments Inc. is focused on the early detection of cancer through the use of its patented opto-acoustic imaging technology.

The leading developer, manufacturer, and marketer of advanced intraosseous technology which offers the potential to establish new standaards of clinical excellence in the safe, rapid performance of medical procedres using the intraosseous space. The Wall Street Journal named Vidacare's EZ-IO Vascular Access System its sole Technology Innovation of the Year Gold Award recipient in 2008. Vidacare products are marketed in over 50 countries worldwide.

ViroXis is a biopharmaceutical company focused on developing and commercializing innovative, proprietary, botanical pharmaceuticals derived from Sandalwood oil.

Develops, manufactures and commercializes a broad suite of devices designed to facilitate endovascular procedures, enhance the diagnosis of vascular and structural heart disease, and guide optimal therapies.

Voxelogix Corporation provides the most comprehensive suite of digitally integrated restorative services and products for full arch dental implant patients.